Health stocks were bludgeoned on Wednesday, in line with the broader market, with the Nasdaq and Amex biotechnology indices down 4.2% and 4.5%, respectively.

Among individual stocks, notable movers were:

Orexigen ( OREX), up 24.2% at $5.55

Enzon ( ENZN), up 15.5% at $4.17

Senomyx ( SNMX), up 11.9% at $3.87

OSI Pharmaceuticals ( OSIP), up 5.7% at $37.31

NuVasive ( NUVA), down 17% at $31.05

Savient ( SVNT), down 16% at $3.69

Amylin ( AMLN), down 13% at $6.28

AstraZeneca ( AZN), down 11.5% at $37.14

Vertex ( VRTX), down 10.7% at $23.50

Celera ( CRA), down 10.3% at $9.98
This article was written by a staff member of TheStreet.com.

If you liked this article you might like

Allos: Folotyn Survival Trend in Lung Cancer

Allos: Folotyn Survival Trend in Lung Cancer

Empire State Index: Monday's Headlines

Empire State Index: Monday's Headlines

Astellas Agrees to Buy OSI Pharma for $4B

Astellas Agrees to Buy OSI Pharma for $4B

OSI Pharma, Biogen, Teva Rise to Highs

OSI Pharma, Biogen, Teva Rise to Highs

Bristol-Myers: Analysts' Upgrades, Downgrades

Bristol-Myers: Analysts' Upgrades, Downgrades